Cancer Radiation Therapy Market Outlook (2021-2031)

Cancer Radiation Therapy Market – Advancing Precision Oncology (2025–2031)

The Cancer Radiation Therapy Market remains foundational in modern cancer treatment. Nearly 60% of all cancer patients receive radiation therapy at some stage, reflecting its effectiveness in targeting tumors with minimal invasiveness.

Market Snapshot:

• Valued at USD 57.88 billion in 2024.

• Projected to grow to USD 136.16 billion by 2031.

• CAGR: 13.1% (2025–2031)

Growth Factors:

• Rising global cancer burden and early detection.

• Shift toward non-invasive and outpatient treatments.

• Technological breakthroughs in IMRT, IGRT, and proton therapy.

Segment Breakdown:

• By Type: External Beam dominates; brachytherapy grows for prostate and cervical cancer.

• By Cancer Type: Breast, lung, and prostate are the top treated.

• By End User: Hospitals and radiotherapy centers are primary service providers.

Technology and Innovation:

• Integration of AI for treatment planning and precision.

• Personalized medicine models enhancing therapy accuracy.

• Expanding clinical research in radiotherapy-drug combinations.

Geographic Insights:

• North America leads in innovation and insurance coverage.

• Asia-Pacific sees highest CAGR due to population and infrastructure growth.

• Emerging markets are investing heavily in mobile radiotherapy units.